A selection of major announcements

1. China Resources Land's total contract sales amount in February was 24.2 billion yuan, an increase of 146.7% over the previous year

$CHINA RES LAND (01109.HK)$An announcement was issued that as of the month ending February 28, 2023, the company and its subsidiaries (groups) achieved total contract sales of about RMB 24.20 billion, and total contract sales floor area of about 952,500 square meters, an increase of 146.7% and 55.2% respectively over the previous year. The cumulative contract sales volume for 2023 was about RMB 40.22 billion, and the total contract sales floor area was about 1,667,900 square meters, an increase of 60.4% and a decrease of 1.1%, respectively, from year to year.

2. Huadian International Electric Power Co., Ltd.: Losses attributable to shareholders in 2022 are expected to narrow by 3.142 billion to 3.442 billion yuan year-on-year

$HUADIAN POWER (01071.HK)$According to the announcement, the Group expects this year's profit or loss attributable to equity holders of the company for the year ending December 31, 2022 to be between a loss of RMB 200 million and a profit of RMB 100 million, a decrease of about RMB 3.142 billion to RMB 3.442 billion compared to the same period last year.

3. Television broadcaster Fa Ying Police: Shareholders' attributable loss is expected to increase to HK$790-830 million year-on-year in 2022

$TVB (00511.HK)$According to the announcement, the Group's consolidated revenue increased by about 24% from HK$2,899 million for the year ended December 31, 2021 (fiscal year 2021) to about HK$3,586 million for the year ending December 31, 2022. The Group expects EBITDA losses of about HK$338 million for fiscal year 2022, while the EBITDA loss for fiscal year 2021 was approximately HK$314 million. As a result, the loss attributable to the company's shareholders in fiscal year 2021 was HK$647 million, and the loss attributable to the company's shareholders increased from HK$790 million to HK$830 million year-on-year.

4. China will invest 1,228 million yuan to participate in the capital increase of China Expatriate Personnel Service Co., Ltd.

$CTG DUTY-FREE (01880.HK)$Announce Board Meeting Resolutions. The conference deliberated and passed the “Bill on Investing in China Expatriate Personnel Service Co., Ltd.”, and the company invested RMB 1,228 million to participate in the capital increase of China Expatriate Personnel Service Co., Ltd. through a private agreement.

5. Maibo Pharmaceutical received the marketing registration application for CMAB009 (for the treatment of metastatic colorectal cancer) by the National Drug Administration

$MABPHARM-B (02181.HK)$It was announced that recently, the listing registration application (NDA) for CMAB009, one of the company's core products, was accepted by China's National Drug Administration for the treatment of metastatic colorectal cancer. In addition to CMAB009, CMAB008 discontinue® (injectable infliximab) has been approved for marketing, and CMAB007 (omalizumab) will soon be approved for marketing by the National Drug Administration.

6. Bank of China Hong Kong: Application for additional RMB counters

$BOC HONG KONG (02388.HK)$According to the announcement, the company has submitted an application for additional RMB counters for the company's shares to the Stock Exchange on March 14, 2023, as a sign of support for the HKD/RMB dual counter model proposed by the Stock Exchange.

Financial data

Yamei Energy (02686)'s profit in 2022 increased 73.61% to 1,416 million yuan

China Aircraft Leasing (01848) revenue of HK$4.17 billion in 2022 increased 27.2% year-on-year

The annual net profit of Changjiang Life Technology (00775) fell 18.94% to HK$132 million

Performance Forecast

Xinyi Power Storage (08328) issued a profit warning. It is expected that the annual shareholders' share of comprehensive net profit will decrease by 25% to 35%

Federal Pharmaceutical (03933) Yingxi: Profit is expected to increase sharply to about 1.5 billion yuan in 2022

Goldland Commercial Investment (00535) expects net profit of about 2.1 billion yuan to 2.5 billion yuan in 2022

TV broadcast (00511) Profit Alert: Expected annual shareholders' losses of approximately HK$790 million to HK$830 million

Yunfeng Financial (00376) expects a net loss of approximately HK$260 million in 2022

Yongtai Real Estate (00369) Profit Police: Losses may be recorded in 2022

Mergers and acquisitions

Fosun International (00656) plans to sell 60% of Nanjing Nangang Steel's shares and acquire 174 million shares of Wansheng (603010.SH)

Shanghai Electric (02727) plans to transfer 100% of Xinji Company's shares for 687 million yuan

Investment and operation

Yasheng Pharmaceutical-B (06855): Three recent pre-clinical developments will be presented at the 2023 American Association for Cancer Research Annual Meeting

Yunfeng Financial (00376): Fitch maintains Yantong Insurance's “A-” (strong) insurance company's financial strength rating unchanged

Hutong Pharmaceutical (00013) has completed a licensing agreement with Takeda for fruquintinib outside of China

Repurchase cancellation

Taikoo Corporation A (00019) spent HK$386.061 million to repurchase 652,000 shares on March 14

AIA (01299) spent HK$132 million to repurchase 1,629 million shares on March 14

Zhonglian Heavy Industry (01157) spent 44,83887 million yuan to buy back about 7 million A-shares on March 14

Lizhu Pharmaceutical (01513) spent 31,587 million yuan to buy back 911,000 A-shares on March 14

Yum China (09987) spent $1 million to buy back 16,800 shares on March 13

Equity incentives

Standard Chartered Group (02888) awarded a total of 22.9 million shares

Yixin Group (02858) awarded a total of 4.4 million reward shares

edit/ruby